Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Operating Leases (2020 - 2025)

Historic Operating Leases for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $44000.0.

  • Journey Medical's Operating Leases changed N/A to $44000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $44000.0, marking a year-over-year change of. This contributed to the annual value of $118000.0 for FY2024, which is 121111.11% up from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Operating Leases is $44000.0.
  • Journey Medical's Operating Leases' 5-year high stood at $118000.0 during Q4 2024, with a 5-year trough of $9000.0 in Q4 2023.
  • Its 5-year average for Operating Leases is $64300.0, with a median of $64000.0 in 2023.
  • As far as peak fluctuations go, Journey Medical's Operating Leases plummeted by 9166.67% in 2023, and later soared by 121111.11% in 2024.
  • Journey Medical's Operating Leases (Quarter) stood at $24000.0 in 2021, then surged by 350.0% to $108000.0 in 2022, then tumbled by 91.67% to $9000.0 in 2023, then soared by 1211.11% to $118000.0 in 2024, then crashed by 62.71% to $44000.0 in 2025.
  • Its last three reported values are $44000.0 in Q3 2025, $69000.0 for Q2 2025, and $94000.0 during Q1 2025.